Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

South Korea

Samsung Medical Center, Seoul